05 Feb 2014, BioSpectrum Bureau , BioSpectrum
Bangalore: Baxter has constructed its R&D center at Biocon's Syngene facility. The facility, which was developed as a collaborative effort between the two organizations, has been named Baxter Global Research Center (BGRC).
The center was inaugurated by Mr Ghulam Nabi Azad, Minister of Health and Family Welfare, Government of India. This initiative is a part of Baxter's global strategy of building its R&D collaborations.
A workforce comprising of 100 scientists and experts is expected to do R&D at this center, focusing on product development, analytical and pre-clinical solutions.
In his speech, Mr Azad commented, "There are several opportunities available for producing immunomodulators for the treatment of immune-deficient diseases, cancer and other non-communicable diseases (NCDs) by the application of modern biotechnology and nanotechnology."
Talking about the country's regulatory mechanism, he said, "At the government level, we are working towards improving regulatory processes. We should have a transparent regulatory mechanism but not at the cost of new innovations. We do not want to kill innovation. We want innovations to happen in our country."